# Model Card: Cancer Histopathology Classification

## Model Details

**Model Name:** Cancer Quantitative Histopathology Model  
**Version:** 0.1.0  
**Date:** 2025-01-15  
**Model Type:** Deep Learning - Image Classification  
**License:** MIT

### Model Architectures

The system supports three main architectures:

1. **ResNet** (ResNet-18, 34, 50, 101, 152)
   - Residual connections for deep networks
   - ImageNet pretrained weights
   - Proven performance on medical images

2. **EfficientNet** (B0-B7)
   - Compound scaling for efficiency
   - State-of-the-art accuracy-efficiency tradeoff
   - Suitable for resource-constrained environments

3. **Vision Transformer** (ViT-Tiny, Small, Base, Large)
   - Attention-based architecture
   - Captures global context
   - Latest in computer vision

## Intended Use

### Primary Use Cases

- **Research**: Quantitative analysis of cancer histopathology images
- **Feature Extraction**: Generate quantitative features for downstream analysis
- **Explainability**: Understand model predictions via Grad-CAM
- **Baseline Model**: Benchmark for cancer classification tasks

### Out-of-Scope Uses

- **NOT** for clinical diagnosis without expert oversight
- **NOT** for unsupervised deployment in patient care
- **NOT** for populations/stain types significantly different from training data

## Training Data

- **Source:** Kaggle histopathology datasets (user-specified)
- **Modality:** H&E stained tissue slides
- **Resolution:** Patches/tiles from whole slide images
- **Classes:** Binary (cancer/non-cancer) or multi-class
- **Preprocessing:** Standardization, augmentation, normalization

## Performance

### Metrics

Evaluated using:
- Accuracy
- AUC-ROC (Area Under ROC Curve)
- Precision, Recall, F1-Score
- Per-class metrics
- Calibration metrics (Brier score, ECE)

### Expected Performance

Performance varies by dataset and architecture. Typical ranges:

- **AUC-ROC:** 0.85 - 0.98
- **Accuracy:** 80% - 95%
- **F1-Score:** 0.78 - 0.94

**Note:** These are reference values. Actual performance depends on dataset quality, size, and class balance.

## Limitations

1. **Generalization:** Model may not generalize to:
   - Different staining protocols
   - Different scanners/magnifications
   - Different tissue types
   - Different cancer subtypes not in training data

2. **Data Requirements:**
   - Requires sufficient labeled training data
   - Performance degrades with class imbalance
   - Sensitive to image quality

3. **Computational:**
   - GPU recommended for training
   - Inference can run on CPU but slower
   - Larger models (ViT, EfficientNet-B7) require more memory

4. **Interpretability:**
   - Grad-CAM provides visual explanations but not complete understanding
   - Black-box nature of deep learning models

## Ethical Considerations

- **Bias:** Model may inherit biases from training data
- **Transparency:** Predictions should be explainable to pathologists
- **Human Oversight:** Should augment, not replace, expert diagnosis
- **Privacy:** Handle patient data according to HIPAA/GDPR regulations

## Recommendations

1. Always validate on institution-specific data before deployment
2. Use ensemble methods for higher confidence
3. Implement threshold tuning for optimal precision-recall tradeoff
4. Monitor performance drift over time
5. Maintain human expert in the loop

## Contact

For questions or issues, please contact the development team or open an issue on GitHub.

## References

- He et al., "Deep Residual Learning for Image Recognition"
- Tan & Le, "EfficientNet: Rethinking Model Scaling for Convolutional Neural Networks"
- Dosovitskiy et al., "An Image is Worth 16x16 Words: Transformers for Image Recognition at Scale"
- Selvaraju et al., "Grad-CAM: Visual Explanations from Deep Networks via Gradient-based Localization"
